Pharm Plan Minutes 2018.10.18

Minutes

Attendees

• Leonidas Tzimis
• Marc Robberecht
• Jacqueline Surugue
• Stephane Spahni
• Jurrian van der Werf
• Esther Peelen
• Jose Costa Teixeira
• Michael Tan*

• Planning of F2F in Vienna in 2019 will be difficult because Juergen cannot attend.
• Review possibilities of organizing the meeting on February 25 2019 in Rotterdam
• Action Michael.

9:00 -10:30 Adverse Event Reporting

• NWI planning en schedule
• Use case and input.
  • see chart Michael
  • anonimous: Not in Greece. Drug is also identified.
  • Lareb uses pseudoniem between hospital and National body.
  • patients also have the possibility to report adverse events directly to the regional or national body.
  • This also could be direct through the hospital or primary care.
• distinction between spontaneous reporting (10.000) and the reporting in the care process.(1000).
  • in the latter you can collect data which is already registered in the process.
• Discussion of the starting point of the ADR. It could be just an incident. At a certain point a drug is suspected.
• In our profile we would start where suspicion is focussed on a drug.
• In the definition of Lareb the ADR is defined by intervention of the care provider in the drug therapy.

• • Yellow card is for drugs, white card is for devices.
• Status of FHIR resource
• set the scope of of the workitem without trespassing domains of PCC and QRPH.

11:00- 12:30 Adverse Event Reporting

• Define work items and next steps.
• Work on Technical Supplement

14:00 - 15:30 Medication Information Sharing

This includes the IDMP, Medication knowledge and supporting HL7 resources. Question form International Board to think about IDMP. Understanding the influence of IDMP

15:45 - 17:00 Supply topics

Status update Plans to pick up supply . including planning. Scope. Priorities. Project members.

17:00 - Adjourn

Pharmacy Technical Committee